`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`MERCK SHARP & DOHME CORP.,
`Petitioner,
`
`v.
`
`GENENTECH, INC. AND CITY OF HOPE,
`Patent Owners.
`
`————————————————
`
`Case IPR2016-00710
`Patent 6,331,415
`
`————————————————
`
`
`
`PETITIONER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1001 U.S. Patent No. 6,331,415
`
`1002 U.S. Patent No. 4,495,280
`
`The ‘415
`patent
`
`Bujard, or the
`Bujard Patent
`
`1003
`
`Riggs and Itakura, Synthetic DNA and Medicine,
`American Journal of Human Genetics, 31:531-538
`(1979)
`
`Riggs &
`Itakura
`
`1004
`
`Southern and Berg, Transformation of Mammalian
`Cells to Antibiotic Resistance with a Bacterial Gene
`Under Control of the SV40 Early Region Promoter,
`Journal of Molecular and Applied Genetics, 1:327341
`(1982)
`
`1005 U.S. Patent No. 4,237,224
`
`1006
`
`Declaration of Jefferson Foote, Ph.D., in Support of
`Sanofi And Regeneron’s Petition for Inter Partes
`Review of U.S. Patent No. 6,331,415
`
`1007 U.S. Patent No. 4,816,657
`
`Southern
`
`Cohen &
`Boyer,
`or the Cohen &
`Boyer patent
`
`Foote Decl.
`
`The Cabilly I
`patent
`
`1008
`
`’415 patent reexamination, Office Action dated
`2/16/07
`
`Office Action
`(2/16/07)
`
`1009
`
`’415 patent reexamination, Owners’ Resp. dated
`11/25/05
`
`Owners’ Resp.
`(11/25/05)
`
`
`
`1
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1010
`
`’415 patent reexamination, Owners’ Resp. (5/21/07)
`
`Owners’ Resp.
`(5/21/07)
`
`1011
`
`’415 patent reexamination, Office Action dated
`9/13/05
`
`Office Action
`(9/13/05)
`
`1012 U.S. Patent No. 4,816,397
`
`1013
`
`’415 patent file history, paper no. 17
`
`1014
`
`’415 patent file history, paper no. 14
`
`1015
`
`’415 patent file history, paper no. 18
`
`The Boss
`patent
`
`-
`
`-
`
`-
`
`1016
`
`’415 patent reexamination, Office Action dated
`8/16/06
`
`Office Action
`(8/16/06)
`
`1017
`
`’415 patent reexamination, Office Action dated
`2/25/08
`
`Office Action
`(2/25/08)
`
`1018 U.S. Patent No. 4,399,216
`
`1019 U.S. Patent No. 5,840,545
`
`1020
`
`Rice and Baltimore, Regulated Expression of an
`Immunoglobulin K Gene Introduced into a Mouse
`Lymphoid Cell Line, Proceedings of the National
`Academy of Sciences USA, 79:7862-7865 (1982)
`
`Axel, or the
`Axel patent
`
`Moore, or the
`Moore patent
`
`Rice &
`Baltimore
`
`1021 Ochi et al., Transfer of a Cloned Immunoglobulin
`Light-Chain Gene to Mutant Hybridoma Cells
`
`Ochi (I)
`
`
`
`2
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`Restores Specific Antibody Production, Nature,
`302:340-342 (1983)
`
`1022
`
`’415 patent reexamination, Owners’ Resp. dated
`10/30/06
`
`Owners’ Resp.
`(10/30/06)
`
`1023
`
`’415 patent reexamination, Owners’ Resp. dated
`6/6/08
`
`Owners’ Resp.
`(6/6/08)
`
`1024
`
`’415 patent reexamination, Appeal Brief
`
`Appeal Brief
`
`1025
`
`’415 patent reexamination, Notice of Intent to Issue
`Ex Parte Reexamination
`
`NIRC
`
`1026
`
`’415 reexamination, Ex Parte Reexamination
`Certificate
`
`Reexam Cert.
`
`1027
`
`T.J.R. Harris, Expression of Eukaryotic Genes in E.
`Coli, in Genetic Engineering 4, 127-185 (1983)
`
`Harris
`
`1028
`
`’415 patent reexamination, Declaration of Dr.
`Timothy John Roy Harris under 37 C.F.R. § 1.132
`
`Harris Decl.
`
`1029
`
`Kabat et al., Sequences of Proteins of Immunological
`Interest (1983) (excerpt)
`
`1030
`
`Cohen, Recombinant DNA: Fact and Fiction,
`Science, 195:654-657 (1977)
`
`1031
`
`Oi et al., Immunoglobulin Gene Expression in
`Transformed Lymphoid Cells, Proceedings of the
`National Academy of Sciences USA, 80:825-829
`(1983)
`
`Kabat
`
`Cohen
`
`Oi
`
`
`
`3
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1032
`
`European Patent Application Publication No.
`0044722 A1, published 1/27/82
`
`Kaplan
`
`1033 U.S. Patent No. 4,487,835
`
`1034 U.S. Patent No. 4,371,614
`
`1035 U.S. Patent No. 4,762,785
`
`1036 U.S. Patent No. 4,476,227
`
`1037 U.S. Patent No. 4,362,867
`
`1038 U.S. Patent No. 4,396,601
`
`1039
`
`Milstein, Monoclonal Antibodies from Hybrid
`Myelomas, Proceedings of the Royal Society of
`London, 211:393-412 (1981)
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`1040
`
`Ochi et al., Functional Immunoglobulin M Production
`after Transfection of Cloned Immunoglobulin Heavy
`and Light Chain Genes into Lymphoid Cells,
`Proceedings of the National Academy of Sciences
`USA, 80:6351-6355 (1983)
`
`Ochi (II)
`
`1041
`
`MedImmune, Inc. v. Genentech, Inc., No. 03-02567
`(C.D. Cal. Aug. 17, 2007), Expert Report of E. Fintan
`Walton
`
`Walton Expert
`Rep.
`
`1042
`
`’415 patent reexamination, Request for
`Reconsideration and/or Petition Under 37 C.F.R. §
`1.183 dated 5/15/09
`
`Request for
`Reconsiderati
`on
`
`
`
`4
`
`
`
`Description
`
`Abbreviation
`
`Exhibit
`No.
`
`1043
`
`Feldman et al., Lessons from the Commercialization of
`the Cohen-Boyer Patents: The Stanford University
`Licensing Program, in Intellectual Property
`Management in Health and Agricultural Innovation: A
`Handbook of Best Practices, 1797-1807 (2007)
`
`Feldman
`
`ReoPro®
`Prescribing
`Info.
`
`1044 ReoPro® Prescribing Information
`
`1045
`
`Genentech v. Centocor, No. 94-01379 (N.D. Cal.),
`Affidavit of John Ghrayeb, Ph.D.
`
`Ghrayeb Aff.
`
`1046
`
`’415 patent reexamination, Declaration of Dr. E.
`Fintan Walton under 37 C.F.R. § 1.132
`
`Walton Decl.
`
`1047
`
`Complaint in MedImmune v. Genentech, No. 03-
`02567 (C.D. Cal.)
`
`1048
`
`Stipulation and order of dismissal in MedImmune v.
`Genentech, No. 03-02567 (C.D. Cal.)
`
`1049
`
`Complaint in Centocor v. Genentech, No. 08-CV-
`3573 (C.D. Cal.)
`
`1050
`
`Order of dismissal in Centocor v. Genentech, No.
`08-CV-3573 (C.D. Cal.)
`
`1051
`
`Complaint in Glaxo Group Ltd. v. Genentech, No.
`10-02764 (C.D. Cal.)
`
`1052
`
`Order of dismissal in Glaxo Group Ltd. v.
`Genentech, No. 10-02764 (C.D. Cal.)
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`5
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1053
`
`Complaint in Human Genome Sciences v.
`Genentech, No. 11-CV-6519 (C.D. Cal.)
`
`1054
`
`Order of dismissal in Human Genome Sciences v.
`Genentech, No. 11-CV-6519 (C.D. Cal.)
`
`1055
`
`Complaint in Eli Lilly and ImClone Systems LLC v.
`Genentech, No. 13-CV-7248 (C.D. Cal.)
`
`1056
`
`Stipulation of dismissal in Eli Lilly and ImClone
`Systems LLC v. Genentech, No. 13-CV-7248 (C.D.
`Cal.)
`
`1057
`
`Complaint in Bristol-Myers Squibb v. Genentech,
`No. 13-CV-5400 (C.D. Cal.)
`
`1058
`
`Stipulation of dismissal in Bristol-Myers Squibb v.
`Genentech, No. 13-CV-5400 (C.D. Cal.)
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`1059
`
`Declaration of Kathryn Calame, Ph.D., in Support of
`Mylan Pharmaceuticals Inc.’s Petition for Inter Partes
`Review of U.S. Patent No. 6,331,415
`
`Calame Decl.
`
`1060 Curriculum Vitae of Kathryn Calame, Ph.D.
`
`-
`
`1061
`
`Declaration of William A. Rakoczy in Support of
`Mylan Pharmaceuticals Inc.’s Unopposed Motion for
`Pro Hac Vice Admission in IPR2016-00710
`
`Rakoczy Decl.
`
`1062
`
`Declaration of Eric R. Hunt in Support of Mylan
`Pharmaceuticals Inc.’s Unopposed Motion for Pro
`Hac Vice Admission in IPR2016-00710
`
`Hunt Decl.
`
`
`
`6
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1063
`
`Declaration of Heinz J. Salmen in Support of Mylan
`Pharmaceuticals Inc.’s Unopposed Motion for Pro
`Hac Vice Admission in IPR2016-00710
`
`Salmen Decl.
`
`1064
`
`Space filling model of antibody Immunoglobulin G
`(NOT FILED)
`
`-
`
`1065
`
`Amster et al., Synthesis of Part of a Mouse
`Immunoglobulin Light Chain in a Bacterial Clone,
`Nucleic Acids Research, 8:2055-2065 (1980) (NOT
`FILED)
`
`Amster
`
`1066
`
`Kurokawa et al., Expression of Human
`Immunoglobulin E ɛ Chain cDNA in E. Coli, Nucleic
`Acids Research, 11:3077-3085 (1983) (NOT FILED)
`
`Kurokawa
`
`1067
`
`Declaration of David Baltimore in Support of U.S.
`Patent No. 6,331,415 (NOT FILED)
`
`Baltimore
`Decl.
`
`1068 Reserved
`
`1069
`
`Berg, Dissections and Reconstructions of Genes and
`Chromosomes, Science, 213:296-303 (1981)
`
`1070
`
`Excerpted File History of U.S. Patent 6,331,415
`(NOT FILED)
`
`-
`
`Berg
`
`-
`
`1071
`
`Stenesh, Dictionary of Biochemistry, 203, 205, 220,
`256 (1975)
`
`Stenesh
`
`1072
`
`Pauza et al., Genes Encoding Escherichia Coli
`Aspartate Transcarbamoylase: The pyrB-pyrI Operon,
`
`Pauza
`
`
`
`7
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`Proceedings of the National Academy of Sciences
`USA, 79:4020-4024 (1982)
`
`1073
`
`Wild et al., A Mutation in the Catalytic Cistron of
`Aspartate Carbamoyltransferase Affecting Catalysis,
`Regulatory Response and Holoenzyme Assembly,
`Nature, 292:373-375 (1981)
`
`1074 Reserved
`
`Roof et al., The Organization and Regulation of the
`pyrBI Operon in E. Coli Includes a Rho-Independent
`Attenuator Sequence, Molecular and General Genetics,
`187:391-400 (1982)
`
`Wild
`
`-
`
`Roof
`
`1075
`
`1076
`
`Navre and Schachman, Synthesis of Aspartate
`Transcarbamoylase in Escherichia Coli:
`Transcriptional Regulation of the pyrB-pyrI Operon,
`Proceedings of the National Academy of Sciences
`USA, 80:1207-1211 (1983)
`
`Navre &
`Schachman
`
`1077 U.S. Patent No. 4,418,149 (NOT FILED)
`
`-
`
`Jolly et al., Isolation and Characterization of a Full-
`Length Expressible cDNA for Human Hypoxanthine
`Phosphoribosyltransferase, Proceedings of the
`National Academy of Sciences USA, 80:477-481
`(1983) (NOT FILED)
`
`Jolly
`
`Stueber and Bujard, Transcription from Efficient
`Promoters Can Interfere with Plasmid Replication
`and Diminish Expression of Plasmid Specified
`Genes, The EMBO Journal, 1:1399-1404 (1982)
`(NOT FILED)
`
`Stueber 1982
`
`8
`
`1078
`
`1079
`
`
`
`
`
`Exhibit
`No.
`
`1080
`
`Description
`
`Abbreviation
`
`Stueber et al., A Novel In Vitro Transcription-
`Translation System: Accurate and Efficient Synthesis of
`Single Proteins from Cloned DNA Sequences, The
`EMBO Journal, 3:3143-3148 (1984) (NOT FILED)
`
`Stueber 1984
`
`1081 US Patent No. 6,541,224 (NOT FILED)
`
`1082
`
`Notice of Deposition of Julie Davis in IPR2016-
`00710 (NOT FILED)
`
`-
`
`-
`
`1083
`
`Petition for Inter Partes Review of U.S. Patent No.
`6,331,415 (NOT FILED)
`
`Petition
`
`1084
`
`Deposition Transcript of Kathryn Calame in
`IPR2016-00710 (NOT FILED)
`
`Calame Dep.
`Tr.
`
`1085 U.S. Patent No. 4,740,470 (NOT FILED)
`
`1086 U.S. Patent No. 4,237,224 (NOT FILED)
`
`1087 U.S. Patent No. 4,468,464 (NOT FILED)
`
`-
`
`-
`
`-
`
`1088
`
`Bera, The Story of the Cohen-Boyer Patents, Current
`Science, 96:760-763 (2009) (NOT FILED)
`
`Bera
`
`Settlement Agreement between Petitioner Mylan
`Pharmaceuticals Inc. and Patent Owner Genentech,
`Inc.
`
`1089
`
`(CONFIDENTIAL - FILED AS BOARD ONLY)
`
`1090
`
`Rebuttal Declaration of Roger D. Kornberg in
`Support of Petitioners’ Reply
`
`-
`
`-
`
`
`
`9
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1091
`
`Declaration of Marc J. Shulman in Support of
`Petitioners’ Reply
`
`1092
`
`Declaration of Louis G. Dudney, CPA, CFF
`(PROTECTIVE ORDER MATERIAL)
`
`1093
`
`Declaration of Atsuo Ochi in Support of Merck’s
`Reply to Patent Owner’s Response
`
`1094 Declaration of Nobumichi Hozumi
`
`1095
`
`Maniatis, Molecular Cloning: A Laboratory Manual,
`Cold Spring Harbor Laboratory (1982)
`
`1096
`
`1097
`
`1098
`
`1099
`
`Wigler et al., Transfer of purified herpes virus
`thymidine kinase gene to cultured mouse cells, Cell
`11(1):223-32 (1977)
`
`Wigler et al., Transformation of mammalian cells
`with genes from procaryotes and eucaryotes, Cell
`16(4):777-85 (1979)
`
`Walter L. Miller. Use of Recombinant DNA
`Technology for the Production of Polypeptides, Adv.
`Exp. Med. Biol., 118: 153-174 (1979)
`
`Turnbough et al., Attenuation Control of pyrBI
`Operon Expression in Escherichia coli K-12, Proc.
`Natl. Acad. Sci. USA, 80:368-372 (January 1983)
`
`1100 Baptist, et al., Identification of the Salmonella
`typhimurium cysB Gene Product by Two-
`
`
`
`10
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`Dimensional Protein Electrophoresis, J. Bacter.
`151:495-499 (July 1982)
`
`1101
`
`Mosher, et al., Synthesis and Secretion of
`Thrombospondin by Cultured Human Endothelial
`Cells, J. Cell Biol. 93:343-348 (May 1982)
`
`1102
`
`Kornberg, Chromatin Structure: Oligomers of the
`Histones, Science 184:865 (1974)
`
`1103
`
`Kornberg, Chromatin Structure: A Repeating Unit of
`Histones and DNA, Science 184:868 (1974)
`
`1104
`
`Thomas & Kornberg, An octamer of histones in
`chromatin and free in solution, Proc. Nat’l Acad.
`Sci. USA 72:2626 (1975)
`
`1105
`
`Henderson’s Dictionary of Biological Terms at 274
`(9th ed. 1979)
`
`1106
`
`Stenesh, Dictionary of Biochemistry and Molecular
`Biology at 312, 333 (2nd ed. 1989)
`
`1107
`
`Dorland’s Illustrated Medical Dictionary at 1206
`(31st ed. 1990)
`
`1108
`
`Tirri, et al., Elsevier’s Dictionary of Biology at 443
`(1st ed. 1998)
`
`1109
`
`Kahl, The Dictionary of Gene Technology Terms at
`305 (2001)
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`11
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1110
`
`King, et al, Dictionary of Genetics at 288 (7th ed.
`2006)
`
`1111
`
`’715 (Morrison) File History, 1/3/92 Response and
`Oi & Morrison Declarations
`
`1112
`
`’715 (Morrison) File History, 8/23/93 Response and
`Herzenberg Declarations
`
`1113
`
`Deposition of John Fiddes Ph.D., taken in IPR2016-
`00710
`
`1114 Deposition of Reiner Gentz, taken in IPR2016-00710
`
`1115 Deposition of Reiner Gentz taken in IPR2015-01624
`
`1116
`
`Deposition of John Fiddes, Ph.D. taken in IPR2015-
`01624
`
`1117
`
`1118
`
`1119
`
`Shulman, Wilde, and Köhler, A better cell line for
`making hybridomas secreting specific antibodies.
`Nature 276: 269-270 (1978)
`
`Köhler, Georges, and Shulman. Immunoglobulin M
`mutants. European Journal of Immunology 10.6
`467-476 (1980)
`
`Hawley et al., N. Mutant immunoglobulin genes have
`repetitive DNA elements inserted into their
`intervening sequences. Proc Natl Acad Sci USA 79,
`7425-7429 (1982)
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`12
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1120
`
`Mulligan and Berg, Expression of a bacterial gene in
`mammalian cells. Science 209: 1422-1427 (1980)
`
`1121
`
`Deposition of Julie Davis, taken in IPR2016-00710
`(PROTECTIVE ORDER MATERIAL)
`
`1122
`
`Battersby and Grimes, 2008 Licensing Update at 99-
`100 (2008)
`
`1123
`
`1124
`
`1125
`
`1126
`
`1127
`
`Swiss Pharma International AG v. Biogen Idec,
`IPR2016-00916, Patent Owner Preliminary
`Response, Paper 6
`
`Boehringer Ingelheim International GmbH et al.,
`Genentech, Inc. et al., IPR2015-00415, Patent
`Owner's Preliminary Response, Paper 10
`
`Boehringer Ingelheim International GmbH et al.,
`Genentech, Inc. et al. IPR2015-00417, Patent Owner
`Preliminary Response, Paper 9
`
`Mylan Pharmaceuticals, Inc. v. Genentech, Inc.,
`IPR2016-01693, Patent Owner's Preliminary
`Response, Paper 11
`
`Mylan Pharmaceuticals, Inc. v. Genentech, Inc.,
`IPR2016-01694, Patent Owner's Preliminary
`Response, Paper 9
`
`1128
`
`Application For Patent Term Extension for U.S.
`Patent No. 5,670,373
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`13
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1129
`
`Application For Patent Term Extension for U.S.
`Patent No. 6,602,684
`
`1130
`
`Application For Patent Term Extension for U.S.
`Patent No. 7,097,840
`
`1131
`
`1132
`
`Coherus Biosciences Inc. v. AbbVie Biotechnology
`Ltd., IPR2016-00188, Patent Owner’s Preliminary
`Response, Paper 7
`
`Swiss Pharma International AG v. Biogen Idec,
`IPR2016-00915, Patent Owner Preliminary
`Response, Paper 6
`
`1133
`
`Application For Patent Term Extension for U.S.
`Patent No. 6,355,245
`
`1134
`
`Application For Patent Term Extension for U.S.
`Patent No. 7,166,285
`
`1135
`
`Application For Patent Term Extension for U.S.
`Patent No. 6,984,720
`
`1136
`
`Schorsch, Kristen. “How AbbVie has won the
`Humira fight – so far.” Crain’s Chicago Business,”
`November 5, 2016
`
`1137 Ochi, Binder: “DNA, RNA Works,” June 1982
`
`1138
`
`Ochi, Binder: “Gene Transfer, B cell hybridomas,”
`Jan. 1983
`
`1139 Coffino P, Knowles B, Nathenson SG, Scharff MD,
`Suppression of immunoglobulin synthesis by cellular
`
`
`
`14
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`hybridization, Nat New Biol. 1971 May
`19;231(20):87-90
`
`1140
`
`Hozumi et al., Abstract “Expression of Cloned
`Immunoglobulin Genes in Heterologous Cells,”
`Submitted to the Fifth International Congress of
`Immunology in Kyoto
`
`1141
`
`Exhibit 5 to the deposition of Reiner Gentz, taken in
`IPR2015-01624
`
`1142
`
`Exhibit 6 to the deposition of Reiner Gentz, taken in
`IPR2015-01624
`
`1143
`
`Exhibit 7 to the deposition of Reiner Gentz, taken in
`IPR2015-01624
`
`1144
`
`Expert Report of John Fiddes, Ph.D., in Bristol-
`Myers Squibb Company v. Genentech, Inc., and City
`of Hope, Case No. 2:13-cv-05400-MRP-JEM
`
`1145
`
`Declaration of John Fiddes, Ph.D., submitted in
`connection with IPR2015-01624
`
`1146
`
`Ochi, Binder: “Gene Transfer, B cell hybridomas,”
`Jul. 1982
`
`1147
`
`’715 (Morrison) File History, 11/1/94 Office Action
`
`1148
`
`Boulianne, G., Hozumi, N., Shulman, M.,
`Production of functional mouse/human antibody,
`Nature 312:643-46 (1984)
`
`
`
`15
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`
`
`Exhibit
`No.
`
`Description
`
`Abbreviation
`
`1149
`
`Markman Hearing Transcript in MedImmune v.
`Genentech, No. 03- 02567 (C.D. Cal.)
`
`1150 U.S. Patent No. 5,807,715
`
`Settlement Agreement between Petitioner Merck
`Sharp & Dohme Corp. and Patent Owner Genentech,
`Inc.
`
`1151
`
`(CONFIDENTIAL - FILED AS BOARD ONLY)
`
`-
`
`-
`
`
`
`
`
`
`
`16
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on May 4, 2017, the
`
`
`
`foregoing document is being served by E-mail by agreement of the parties to the
`
`following counsel of record for the Patent Owners:
`
`David L. Cavanaugh
`David.Cavanaugh@wilmerhale.com
`
`Robert J. Gunther, Jr.
`Robert.Gunther@wilmerhale.com
`
`Heather M. Petruzzi
`Heather.Petruzzi@wilmerhale.com
`
`Owen K. Allen
`Owen.Allen@wilmerhale.com
`
`Adam R. Brausa
`abrausa@durietangri.com
`
`David I. Gindler
`dgindler@irell.com
`
`
`
`
`Dated: May 4, 2017
`
`
`
`
`
`
`
`Michael R. Fleming
`mfleming@irell.com
`
`David F. McGowan
`dmcgowan@durietangri.com
`
`Joseph M. Lipner
`jlipner@irell.com
`
`Daralyn J. Durie
`ddurie@durietangri.com
`
`
`Respectfully submitted,
`
` /Raymond N. Nimrod/
`Raymond N. Nimrod (Reg. No. 31,987)
`QUINN EMANUEL URQUHART
` & SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`raynimrod@quinnemanuel.com
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
